Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 157

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 157
---
 The lack of such a process in connection with the listing of the Company’s securities could result in diminished investor demand, inefficiencies in pricing and a more volatile public price for the Company’s securities during the period immediately following the listing than in connection with an underwritten initial public offering. Risks Related to Our Intellectual Property We primarily rely and expect to rely in the future on trade secrets, copyrights, trademarks, know -how , patents and other forms of intellectual property protections, and if such protections are not adequate our business may be adversely affected. The proprietary positions of companies developing tools for the life sciences, genomics, forensics and pharmaceutical industries generally are uncertain and involve complex legal and factual questions. We rely and expect to rely in the future upon trade secrets, copyrights, trademarks, know -how, patents and other forms of intellectual property protections, to protect our confidential and proprietary information. In addition, we rely and expect to rely in the future upon trade secret protection to protect unpatented know -howand continuing technological innovation, in particular since OmnigenicsAI has not filed any patent applications in any jurisdiction. We have or may acquire in the future know -howrights pertaining to sample type, sample preparation and processing, sample preservation, bioinformatic processing, biomarkers, gene expression and sequencing technology, data analysis through algorithms, and related methods and formulations. Our success will depend upon our ability to develop proprietary methods and databases and to defend any advantages afforded to us by such methods and databases relative to our competitors. If we do not protect our intellectual property adequately, competitors may be able to use our methods and databases and thereby erode any competitive advantages we may have. We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies are covered by valid and enforceable patents or are effectively maintained as trade secrets. In this regard, in the future, we may apply for patents covering such aspects of our technologies as we deem appropriate. However, we expect that potential patent coverage we may obtain will not be sufficient to prevent substantial competition. In this regard, we believe it is probable that others will independently develop similar or alternative technologies or design around those technologies for which we may obtain patent protection. In addition, any patent applications we file may be challenged and may not result in issued patents or may be invalidated or narrowed in 56 scope after they are issued. Questions as to inventorship or ownership may also arise. Any finding that our patents or applications are unenforceable could harm our ability to prevent